1188 related articles for article (PubMed ID: 8720304)
1. Comparative analysis of the cardiotoxicity proclivities of second generation antihistamines in an experimental model predictive of adverse clinical ECG effects.
Hey JA; del Prado M; Sherwood J; Kreutner W; Egan RW
Arzneimittelforschung; 1996 Feb; 46(2):153-8. PubMed ID: 8720304
[TBL] [Abstract][Full Text] [Related]
2. Cardiotoxic and drug interaction profile of the second generation antihistamines ebastine and terfenadine in an experimental animal model of torsade de pointes.
Hey JA; del Prado M; Kreutner W; Egan RW
Arzneimittelforschung; 1996 Feb; 46(2):159-63. PubMed ID: 8720305
[TBL] [Abstract][Full Text] [Related]
3. Antihistamine activity, central nervous system and cardiovascular profiles of histamine H1 antagonists: comparative studies with loratadine, terfenadine and sedating antihistamines in guinea-pigs.
Hey JA; Del Prado M; Cuss FM; Egan RW; Sherwood J; Lin CC; Kreutner W
Clin Exp Allergy; 1995 Oct; 25(10):974-84. PubMed ID: 8556569
[TBL] [Abstract][Full Text] [Related]
4. [The effect of second generation histamine antagonists on the heart].
Grzelewska-Rzymowska I; Pietrzkowicz M; Górska M
Pneumonol Alergol Pol; 2001; 69(3-4):217-26. PubMed ID: 11575008
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetic overview of oral second-generation H1 antihistamines.
González MA; Estes KS
Int J Clin Pharmacol Ther; 1998 May; 36(5):292-300. PubMed ID: 9629995
[TBL] [Abstract][Full Text] [Related]
6. Terfenadine, astemizole, and ebastine produce QTc interval prolongation in an experimental model predictive of adverse clinical ECG effects.
Hey JA; del Prado M; Egan RW; Kreutner W
Ann Allergy Asthma Immunol; 1996 May; 76(5):476. PubMed ID: 8630724
[No Abstract] [Full Text] [Related]
7. Second-generation antihistamines: the risk of ventricular arrhythmias.
DuBuske LM
Clin Ther; 1999 Feb; 21(2):281-95. PubMed ID: 10211532
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the potential cardiotoxicity of the antihistamines terfenadine, astemizole, loratadine, and cetirizine in atopic children.
Delgado LF; Pferferman A; Solé D; Naspitz CK
Ann Allergy Asthma Immunol; 1998 Apr; 80(4):333-7. PubMed ID: 9564984
[TBL] [Abstract][Full Text] [Related]
9. Preclinical in vitro cardiac electrophysiology: a method of predicting arrhythmogenic potential of antihistamines in humans?
Cavero I; Mestre M; Guillon JM; Heuillet E; Roach AG
Drug Saf; 1999; 21 Suppl 1():19-31; discussion 81-7. PubMed ID: 10597865
[TBL] [Abstract][Full Text] [Related]
10. Cardiotoxicity of new antihistamines and cisapride.
Paakkari I
Toxicol Lett; 2002 Feb; 127(1-3):279-84. PubMed ID: 12052668
[TBL] [Abstract][Full Text] [Related]
11. Loratadine and terfenadine interaction with nefazodone: Both antihistamines are associated with QTc prolongation.
Abernethy DR; Barbey JT; Franc J; Brown KS; Feirrera I; Ford N; Salazar DE
Clin Pharmacol Ther; 2001 Mar; 69(3):96-103. PubMed ID: 11240972
[TBL] [Abstract][Full Text] [Related]
12. Potential cardiac toxicity of H1-antihistamines.
Yap YG; Camm AJ
Clin Allergy Immunol; 2002; 17():389-419. PubMed ID: 12113224
[TBL] [Abstract][Full Text] [Related]
13. Comparative antiallergic effects of second-generation H1-antihistamines ebastine, cetirizine and loratadine in preclinical models.
Llupià J; Gras J; Llenas J
Arzneimittelforschung; 2003; 53(2):93-7. PubMed ID: 12642964
[TBL] [Abstract][Full Text] [Related]
14. Safety of antihistamines in children.
Ten Eick AP; Blumer JL; Reed MD
Drug Saf; 2001; 24(2):119-47. PubMed ID: 11235817
[TBL] [Abstract][Full Text] [Related]
15. Treating allergic rhinitis with second-generation antihistamines.
Nightingale CH
Pharmacotherapy; 1996; 16(5):905-14. PubMed ID: 8888086
[TBL] [Abstract][Full Text] [Related]
16. Predictors of torsades de pointes in rabbit ventricles perfused with sedating and nonsedating histamine H1-receptor antagonists.
Gilbert JD; Cahill SA; McCartney DG; Lukas A; Gross GJ
Can J Physiol Pharmacol; 2000 May; 78(5):407-14. PubMed ID: 10841436
[TBL] [Abstract][Full Text] [Related]
17. The current cardiac safety situation with antihistamines.
Yap YG; Camm AJ
Clin Exp Allergy; 1999 Mar; 29 Suppl 1():15-24. PubMed ID: 10209701
[TBL] [Abstract][Full Text] [Related]
18. Advances in the pharmacotherapy of allergic rhinitis: second-generation H1-receptor antagonists.
Corey JP
Otolaryngol Head Neck Surg; 1993 Sep; 109(3 Pt 2):584-92. PubMed ID: 8105440
[TBL] [Abstract][Full Text] [Related]
19. The changing face of antihistamines and cardiac adverse drug reactions: a clinical perspective.
Shaikh WA
J Indian Med Assoc; 2000 Jul; 98(7):397-9. PubMed ID: 11143865
[TBL] [Abstract][Full Text] [Related]
20. Effects of H1 antihistamines on animal models of QTc prolongation.
Gras J; Llenas J
Drug Saf; 1999; 21 Suppl 1():39-44; discussion 81-7. PubMed ID: 10597867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
